3.0T 1H magnetic resonance spectroscopy for assessment of steatosis in patients with chronic hepatitis C

Table 1 Patient demographics and baseline characteristics

	No fatty liver (n = 30)	Mild fatty liver (n = 26)	Moderate fatty liver (n = 16)	Severe fatty liver (n = 9)
Age (yr)	49.8 ± 10.6	53.4 ± 9.8	52.7 ± 10.4	55.6 ± 11.2
Gender	Male 8 (53.33%)	Male 6 (46.15%)	Male 5 (62.5%)a	Male 7 (77.78%)a
HCV-RNA(copies/mL)	5.18 ± 1.20	5.43 ± 1.14	5.23 ± 1.65	5.43 ± 1.47
Child-Plug	3 ± 1	4 ± 1	6 ± 1	7 ± 1
TBIL	12.7 ± 6.7	13.9 ± 6.4	26.6 ± 6.9a	38.7 ± 11.6a
ALT	12.9 ± 10.6	18.8 ± 12.3	62.4 ± 13.2a	103.8 ± 20.3a
AST	10.7 ± 9.9	16.5 ± 10.1	52.5 ± 12.3a	87.7 ± 16.2a
TG	1.2 ± 0.3	1.8 ± 0.4	3.2 ± 1.1a	5.4 ± 2.1a
Chol	2.7 ± 1.2	3.3 ± 1.5	5.4 ± 1.8a	6.7 ± 2.2a
Blood glucose	4.1 ± 0.2	4.3 ± 0.3	5.8 ± 2.0a	7.4 ± 3.3a

^aP < 0.05, vs no fatty liver group and mild fatty liver group.